N7-Methylguanine and O⁶-methylguanine levels in DNA of white blood cells from cancer patients treated with dacarbazine

References

• Augusto O., Cavalieri E. L., Rogan E. G., Rammakrishna N. V. S., Kolar C. Formation of 8-methylguanine as a result of DNA alkylation by methyl radicals generated during horseradish peroxidase-catalyzed oxidation of methylhydrazine. Journal of Biological Chemistry 1990; 265: 22093–22096
   PubMed Web of Science ®Google Scholar
• Bianchini F., Wild C. P. Comparison of 7-medG formation in white blood cells, liver and target organs in rats treated with methylating carcinogens. Carcinogenesis 1994; 15: 1137–1141
   PubMed Web of Science ®Google Scholar
• Buesa J. M., Urzechaga E. Clinical pharmacokinetics of high-dose DTIC. Cancer Chemotherapy Pharmacology 1991; 28: 475–479
   PubMedGoogle Scholar
• van Delft J. H. M., van Weert E. J., Schellekens M. M., Claassen E., Baan R. A. The isolation of monoclonal antibodies selected for the detection of imidazole ringapened N7-ethylguanine in purified DNA and in cells in situ. Crossreaction with methyl, 2-hydroxyethyl and sulphur mustard adducts. Carcinogenesis 1991; 12: 1041–1049
   PubMedGoogle Scholar
• van Delft J. H. M., van den Ende A. M. C., Keizer H. J., Ouwerkerk J., Baan R. A. Determination of N7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazine. Carcinogenesis 1992; 13: 1257–1259
   PubMed Web of Science ®Google Scholar
• van Delft J. H. M., van Winden M. J. M., Luiten-Sctium A., Ribeiro L. R., Baan R. A. Comparison of various immunochemical assays for the detection of ethylene oxide-DNA adducts with monoclonal antibodies against imidazole ring-opened N7-(2-hydroxyethyl)guanosine: application in a biological monitoring study. Carcinogenesis 1994; 15: 1867–1873
   PubMed Web of Science ®Google Scholar
• The Eurogast Study Group O6-Methylguanine in blood leucocyte DNA. an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis. Carcinogenesis 1994; 15: 1815–1820
   PubMedGoogle Scholar
• Frei J. V., Swenson D. H., Warren W., Lawley P. D. Alkylation of deoxyribonucleic acid in vivo in various organs of C57BL mice by the carcinogens N-methyl-N-Nnitrosourea, N-ethyl-Nnitrosourea and ethyl methanesulphonate in relation to induction of thymic lymphoma. Biochemical Journal 1978; 174: 1031–1044
   PubMed Web of Science ®Google Scholar
• Goria-Gatto L., Iannone A., Tomasi A., Par G., Albano E. In vitro and in vivo evidence for the formation of methyl radical from procarbarine: a spin-trapping study. Carcinogenesis 1992; 13: 799–805
   PubMedGoogle Scholar
• Hemminki K. Environmental carcinogens. Chemical Carcinogenesis and, I Mutagenesis, C. S. Cooper, P. L. Grover. Springer-Verlag, Berlin 1990; 33–61
   Google Scholar
• IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. In Dacarbazine. International Agency for Research on Cancer 1981; 26: 203–215
   Google Scholar
• Lee S. M., Thatcher N., Margison G. P. 06-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine. Cancer Research 1991; 51: 619–623
   PubMed Web of Science ®Google Scholar
• Legha S. S. Current therapy for malignant melanoma. Seminars in Oncology 1989; 16(Suppl. 1)34–44
   PubMedGoogle Scholar
• Meer L., Janzer R. C., Kleihues P., Kolar G. F. In vivo metabolism and reaction with DNA of the cytostatic agent, 5-(3,3-dimethyl-1 triazeno)imidazole-4-arboxamide (DTIC). Biochemical Pharmacology 1986; 35: 3243–3247
   PubMedGoogle Scholar
• Mustonen R. Measurement by 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguanines. Carcinogenesis 1991; 12: 1423–1431
   PubMed Web of Science ®Google Scholar
• Mustonen R., Foersti A., Hietanen P., Hemminki K. Development of a 32P-postlabeling assay for 7-methylguanines in human DNA. Environmental Health Perspectives 1993b; 99: 233–235
   PubMedGoogle Scholar
• Mustonen R., Schoket B., Hemminki K. Smoking-related DNA adducts: 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis 1993a; 14: 151–154
   PubMed Web of Science ®Google Scholar
• Pegg A. E. Metabolism of N-nitrosodimethylamine. Molecular and Cellular Aspects of Carcinogen Screening tests, R. Montesano, H. Bartsch, L. Tomatis. IARC Scientific Publication, Lyon 1980; Volume 27: 3–22
   Google Scholar
• Phlip P. A., Souliotis V. L., Harris A. L., Salisbury A., Tates A. D., Mitchell K., van Delft J. H. M., Ganesan T. S., Kyrtopoulos S. A. Methyl DNA adducts, DNA repair and HPRT mutations in peripheral white blood cells from Patients with malignant melanoma treated with dacarbazine and hydroxyurea. Clinical Cancer Research 1995; 2: 303–310
   Google Scholar
• Prough R. A., Tweedie D. J. Procarbazine. Metabolism and Action of Anti-cancer Drugs, G. Powis, R. A. Prough. Taylor & Francis, New York 1988; 29–47
   Google Scholar
• Searle C. E., Teale O. J. Occupational carcinogens. Chemical Carcinogenesis and Mutagenesis I, C. S. Cooper, P. L. Grover. Springer-Verlag, Berlin 1990; 103–151
   Google Scholar
• Singer B., Grunberger D. Molecular Biology of Mutagens and Carcinogens. Plenum Press, New York 1983
   Google Scholar
• Soullotis V. L., Kyrtopoulos S. A. A novel, sensitive assay for O6 methyl- and O6-ethylguanine in DNA, based on repair by the enzyme O6-alkylguanine-DNA-alkyltransferase in competition with an oligonucleotide containing O6-methylguanine. Cancer Research 1989; 49: 6997–7001
   PubMedGoogle Scholar
• Souliotis V. L., Kaila S., Boussiotis V. A., Pangalis G. A., Kyrtopoulos S. A. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Cancer Research 1990; 50: 2759–2764
   PubMed Web of Science ®Google Scholar
• Souliotis V. L., Boussiotis V. A., Pangalis G. A., Kyrtoulos S. A. In vivo formation and repair of O6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine. Carcinogenesis 1991; 12: 285–288
   PubMed Web of Science ®Google Scholar
• Souuons V. L., Valavanis C., Boussiotis V. A., Pangalis G. A., Kyrtopoulos S. A. Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine. Carcinogenesis 1994; 15: 1675–1680
   PubMedGoogle Scholar
• Souliots V. L., Chhabra S. K., Anderson I. M., Kyrtopoulos S. A. Dosimetry of 06-inethylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA). Implications for the mechanism of NDMA hepatocarcinogenesis. Carcinogenesis 1995; 16: 2381–2387
   PubMedGoogle Scholar
• Valavanis C., Souliotis V. L., Kyrtopoulos S. A. Differential effects of procarbazine and methylnitrosourea on the accumulation of O6-methylguanine and the depletion and recovery of O6-alkylguanine-DNA alkyltransferase in rat tissues. Carcinogenesis 1994; 15: 1681–1688
   PubMed Web of Science ®Google Scholar
• van Zeeland A. A., Mohin G. R., Neuhauser-Klaus A., Ehling U. Quantitative comparison of genetic effects of ethylating agents on the basis of DNA adduct formation. Use of O6-ethylguanine as molecular dosimeter for extrapolation from cells in culture to the mouse. Environmental Health Perspectives 1985; 62: 163–169
   PubMedGoogle Scholar